The amniotic membrane market size is anticipated to touch USD 2,690.22 million at a 12.67% CAGR between 2019-2025, states the latest Market Research Future (MRFR) report. The amniotic membrane, also known as amnion, is the deepest layer of the placenta that comprises of an avascular stromal matrix and a thick basement membrane. It is a combination of cells and tissues that aid in wound healing by serving as the foundation for the soft tissues to regrow. Amniotic membrane is widely used as a biological bandage in eye surgery for healing or replacing damaged eye tissue.
On the contrary, lack of awareness about amniotic membrane transplants, scarcity of skilled professionals, and rising healthcare costs are factors that may restrict the amniotic membrane market growth during the forecast period.
Various factors are propelling the amniotic membrane market growth. Such factors, as per the latest Market Research Future report, include its extensive applications in head and neck, brain, skin, genitourinary tract, ophthalmology, and other surgical methods, increasing research activities worldwide, and increasing geriatric population. Additional factors propelling the growth of the amniotic membrane market include increasing amniotic membrane transplantations and rising disease awareness.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5645
Osiris Therapeutics, Inc. (US), Amnio Technology, LLC (US), Human Regenerative Technologies, LLC (US), Katena Products, Inc. (US), Amniox Medical, Inc. (Florida), MiMedx (US), Skye Biologics Inc. (California), Integra LifeSciences (US), AlliquaBioMedical, Inc. (US), and Applied Biologics (US)
The Market Research Future report provides an all-inclusive segmental analysis of the amniotic membrane market on the basis of type & technology (application), and end user.
By type, the Global Amniotic Membrane Market Report is segmented into lyophilized and cryopreserved. Of these, the cryopreserved type will lead the market during the forecast period for the increasing number of ocular surgeries.
By application, the amniotic membrane market is segmented into prenatal diagnosis, regenerative medicine, stem cell biology, ophthalmology, surgical wounds, and others. Of these, the ophthalmology segment will dominate the market during the forecast period. It is used to treat various conditions such as conjunctival surface reconstruction, persistent epithelial defects with ulceration, pterygium, Stevens-Johnson syndrome, cicatricial pemphigoid, and ocular surface reconstruction in those with thermal and chemical burns.
By end user, the amniotic membrane market is segmented into hospitals and clinics, research centers and laboratory, ambulatory surgical centers, and others. Of these, hospitals and clinics will hold the maximum share in the market during the forecast period due to frequent visits made by patients, along with its ability to cater to different surgical interventions.
By region, the amniotic membrane market report covers the latest trends and growth opportunities across Europe, the Asia Pacific, North America, and the Middle East and Africa. Of these, North America will lead the market during the forecast period. Various factors propelling the growth of the amniotic membrane market in the region include growing focus on alternative technologies, adoption of the latest technologies, and the presence of leading companies and well-developed healthcare infrastructure in the region.
The amniotic membrane market in Europe will have the second-largest share in the market during the forecast period. Various factors propelling the growth of the amniotic membrane market in the region include the healthcare system in the region is publicly funded, adoption of universal health care systems, the presence of target population, increase in surgical interventions, and rising incidence of chronic diseases. Germany as well as France are the major contributors in the region.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/amniotic-membrane-market-5645
The amniotic membrane market in the APAC region is predicted to grow at the highest CAGR during the forecast period. Various factors propelling the growth of the amniotic membrane market in the region include developing economy, increasing disposable income, heavy investments being made in the region by multinational companies, and the presence of countries that are technologically advanced with regards to medical and healthcare research. India is a major contributor in this region.
The amniotic membrane market in the MEA will have a small share during the forecast period.
July 2019: Americord Registry has launched Placental Tissue 2.0, its latest stem cell banking product. This exciting product is the first in the industry that will help to store live amniotic membrane. Placental Tissue 2.0 will allow people to store two kinds of valuable stem cells- MSCs (mesenchymal stem cells) and AECs (amniotic epithelial cells).